EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Gain of visceral adipose tissue rather than low skeletal muscle mass is associated with overall survival in patients with colorectal liver metastases; results from the NewEPOC study

Merel R Aberle, Marjolein A P Ligthart, Malcolm A West, Sander S Rensen, Zina Eminton, David P J van Dijk, Sian A Pugh, John A Bridgewater, John N Primrose, Steven W M Olde Damink

European Journal of Surgical Oncology · 2026

DOI: 10.1016/j.ejso.2025.111179 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Surgical Oncology, 2026. Verfasst von Merel R Aberle und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Intra-Abdominal Fat, Liver Neoplasms, Muscle, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK Cambridge Research Institute, Cancer Research UK, NUTRIM School of Nutrition and Translational Research in Metabolism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Sarcopenia and adiposity at diagnosis are important prognostic factors in cancer. Ongoing changes in body composition during chemotherapy treatment may have additional prognostic relevance. This study aimed to investigate the association between body composition changes during neoadjuvant treatment and survival in patients with colorectal liver metastases. MATERIALS & METHODS: In this subgroup analysis of the newEPOC RCT (NCT00482222), pre- and post-treatment CT-scans of patients undergoing neoadjuvant chemotherapy for colorectal liver metastases were studied. The total cross-sectional area of skeletal muscle tissue (SM), Visceral Adipose Tissue (VAT), Subcutaneous Adipose Tissue (SAT), Intra-Muscular Adipose Tissue (IMAT), and radiation attenuation for skeletal muscle (SM-RA) were determined. RESULTS: , p = 0.002, for women. SM-RA decreased from 37.7 ± 7.8 to 36.0 ± 7.6 HU, p 2 % VAT-index over 12 weeks (HR2.05, 95 %CI1.12-3.76, p = 0.025) were. CONCLUSIONS: The body composition features SM and SM-RA decreased during chemotherapy, but were not associated with survival. On the contrary, although VAT did not significantly change, the gain of VAT was an independent prognostic factor for survival. These results should be validated in independent cohorts but may indicate that in this selected patient group, adipose tissue might be a more important prognostic factor than sarcopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsIntra-Abdominal FatLiver NeoplasmsMuscle, SkeletalSarcopeniaHumansMaleFemaleMiddle AgedNeoadjuvant TherapyAgedBody CompositionTomography, X-Ray ComputedSurvival RatePrognosisAntineoplastic Combined Chemotherapy ProtocolsSubcutaneous Fat

Stichwörter der Autor:innen

Body compositionCachexiaCancerColorectal liver metastasesPrognosis

Autor:innen und Institutionen

  • Department of Surgery and NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
  • School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Department of Surgery, University Hospitals Southampton NHS Foundation Trust, Southampton, UK; Perioperative and Critical Care…
  • Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Department of Oncology, Addenbrooke's Hospital, Cambridge, UK.
  • Department of Medical Oncology, University College London Cancer Institute, London, UK.

Förderung

  • Cancer Research UK Cambridge Research Institute
  • Cancer Research UK
  • NUTRIM School of Nutrition and Translational Research in Metabolism
  • Maastricht Universitair Medisch Centrum

Zitieren

APA

Aberle, M. R., Ligthart, M. A. P., West, M. A., Rensen, S. S., Eminton, Z., van Dijk, D. P. J., Pugh, S. A., Bridgewater, J. A., Primrose, J. N., & Olde Damink, S. W. M. (2026). Gain of visceral adipose tissue rather than low skeletal muscle mass is associated with overall survival in patients with colorectal liver metastases; results from the NewEPOC study. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.111179

Vancouver

Aberle MR, Ligthart MAP, West MA, Rensen SS, Eminton Z, van Dijk DPJ, et al. Gain of visceral adipose tissue rather than low skeletal muscle mass is associated with overall survival in patients with colorectal liver metastases; results from the NewEPOC study. European Journal of Surgical Oncology. 2026. doi:10.1016/j.ejso.2025.111179

BibTeX
@article{Aberle2026,
  author = {Aberle, Merel R and Ligthart, Marjolein A P and West, Malcolm A and Rensen, Sander S and Eminton, Zina and van Dijk, David P J and Pugh, Sian A and Bridgewater, John A and Primrose, John N and Olde Damink, Steven W M},
  title = {Gain of visceral adipose tissue rather than low skeletal muscle mass is associated with overall survival in patients with colorectal liver metastases; results from the NewEPOC study},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  doi = {10.1016/j.ejso.2025.111179}
}
Kostenlos starten →